[e-drug] Global Fund Board Cancels Round 11; New Rules for Grant Renewals

E-DRUG: Global Fund Board Cancels Round 11; New Rules for Grant Renewals
------------------------------------------------------------------------
[There has been discussion in E-drug about the recent decision by the Global
Fund Board to cancel round 11, but the original information was not easily
available. Here a good summary of the Global Fund Observer, a free
newsletter available from see www.aidspan.org/gfo.
The funding crisis in Global Fund will limit the number of people that can
be put on treatment. This is a very serious issue. WB]

GFO Issue 167 - 23 November 2011

Board Cancels Round 11 and Introduces Tough New Rules for Grant Renewals

Financial difficulties have caused the Global Fund Board to cancel Round 11.
This difficult decision was made at a stressful two-day Board meeting just
concluded in Accra, Ghana. The Board also announced new rules for grant
renewals in an attempt to find savings that can be applied to funding new
proposals.

The Global Fund Board has cancelled Round 11 in light of the Global Fund's
financial difficulties. This difficult decision was made at a stressful
two-day Board meeting in Accra, Ghana, that ended yesterday evening, 22
November.

The original decision to launch Round 11 in August 2011 was made at a Board
meeting in December 2010. At its meeting in May 2011, the Board did not make
any changes to its plans for Round 11, having been told by the Secretariat
that sufficient funding (an estimated $1.6 billion) would be available for
that round. But the estimate of funds available for Round 11 declined to
$0.8 billion in September 2011, and then to a negative amount this month.
The decline was caused primarily by some donors changing their minds
regarding their so-called pledges, and other donors saying that they would
delay payment of their pledges.

The Global Fund has long had a policy that the financing of Phase 2 renewals
of existing grants has a higher priority than the financing of new grants.
As a result, the Board concluded that almost all of the $8.2 billion in
revenues that is now projected to arrive by the end of 2013 will be needed
for renewals, leaving no money for Round 11.

The next replenishment period will be 2014-2016. Given that there is no
money for Round 11, the next opportunity for countries to apply for new
grants will be during the 2014-2016 period. They will be able to do so using
a new funding model that is called for in the Fund's new Strategy 2012-2016,
also approved at this Board meeting.

Some countries have existing grants that will reach the end of Phase 2 well
before 2014. Many of those countries have been hoping to be approved for
Round 11 grants. Because that will not be possible now, the Board has agreed
to put in place a Transitional Funding Mechanism that will provide for
continuation of essential prevention, treatment and/or care services by
current grantees. Details of this mechanism will likely be announced in the
coming weeks.

However, even with the cancellation of Round 11, the Global Fund did not
have enough money to pay for the Transitional Funding Mechanism, and for
some Round 10 grants, unless further savings could be found. (The Fund
stopped signing Round 10 grant agreements about a week ago because of its
financial problems.)

The Board decided to find some of the required savings in the following
ways:
. The one-year Grace Period provision for changes in country income
classification will be rescinded. (See explanation in GFO 80.)
. The "counterpart financing" and "focus of proposal" requirements that
already apply to new grants will also apply to Phase 2 renewals. (See
description in GFO 146.)
. Instead of Phase 2 financial commitments being made in two tranches (i.e.,
the first two years, and then the third year), they will be made one year at
a time ("1+1+1").

But even more money had to be freed up. The Board discussed two options for
this. One was to say that all eligibility rules that apply to new proposals
would also apply to Phase 2 renewals. The other was to say that countries
are not eligible for Phase 2 renewal of their current grants if they are
Group of 20 (G-20) upper-middle-income countries "with less than an extreme
disease burden." Following a difficult discussion, the Board chose the
second option. This means, for example, that Argentina, Brazil, China,
Mexico and Russian Federation will not be eligible for Phase 2 renewal.
(South Africa is a G-20 country, but it has an "extreme" disease burden, so
it will be allowed through.)

China is, by far, the country that will suffer most from this decision,
because China had been expecting to be eligible for some $880 million in
grant renewals.

Now that the above measures have been agreed, the Fund will temporarily be
able to resume signing Round 10 grant agreements. However, because the
signing of new grant agreements can only be done when the required funds
have been received by the Global Fund from its donors, and because Phase 2
renewals take priority over new grants, it is always possible that the
signing of Round 10 agreements will be put on hold again. It all depends on
whether donors deliver their 2011 pledges during 2011, and whether at least
some of them deliver their 2012 pledges earlier rather than later in 2012.

The Global Fund Board's decisions concerning Round 11 are contained in the
decisions point document for the Accra meeting, which is due to be posted at
www.theglobalfund.org/en/board/meetings/twentyfifth

E-DRUG: Global Fund Board Cancels Round 11; New Rules for Grant Renewals (2)
-------------------------------------------------------------------------

Dear colleagues,
The cancellation of Round 11 funding is going to be a challenge for recipient governments and institutions. But I wonder whether this situation will also act as an energizer, to get recipient governments to start seriously considering, and in some cases, implementing alternative funding arrangements, even though such schemes may not replace the funding capacity under the GFATM.

Regards,
Bonnie

Bonface Fundafunda PhD., MBA., B.Pharm
Manager, Drug Supply Budget Line
Ministry of Health,
P.O. Box 30205,
Ndeke House,
Lusaka,
Zambia
Tel: +260 211 25 41 83
Fax: +260 211 25 33 44
Mobile: + 260 979 25 29 00
Email: bcfunda@hotmail.com